Next, and to investigate if the effect of DKK3 overexpression on the molecular profile of PCa cells that we observed in vitro was clinically relevant, we next performed RNAseq on biopsies obtained from our patient cohort that include patients with BPH and PCa patients (Figure 4). This evidence concerns the gene DKK3 and benign prostatic hyperplasia.